Cargando…
Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease
The role of albumin in Parkinson disease (PD) is not well understood, our study will investigate the association between the serum albumin level and risk of dementia, motor impairment, as well as survival outcome in PD. Data were obtained from the publicly available dataset in the DRYAD database (ht...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478219/ https://www.ncbi.nlm.nih.gov/pubmed/36123949 http://dx.doi.org/10.1097/MD.0000000000030324 |
_version_ | 1784790520368726016 |
---|---|
author | Sun, Shujun Wen, Yiyong Li, Yandeng |
author_facet | Sun, Shujun Wen, Yiyong Li, Yandeng |
author_sort | Sun, Shujun |
collection | PubMed |
description | The role of albumin in Parkinson disease (PD) is not well understood, our study will investigate the association between the serum albumin level and risk of dementia, motor impairment, as well as survival outcome in PD. Data were obtained from the publicly available dataset in the DRYAD database (https://datadryad.org/). The original prospective study enrolled patients with PD from a single center in Japan between March 2004 and November 2007. Due to missing values, 242 and 274 participants were included in the study, in which we aimed to, respectively, analyze the relationship between serum albumin and cognitive function as well as motor impairment; additionally, 264 participants were included to assess the association between baseline serum albumin levels and risk of PD-related death with a median follow-up of 5.24 years. Compared to patients of the low tertile of albumin levels, Mini-Mental State Examination (MMSE) of patients of middle tertile increased 2.09 [95% confidence interval (CI) (0.45, 3.73), P = .013], independent of age, sex, PD duration, modified Hoehn-Yahr (mHY) stage, C-reactive protein (CRP) level, and use of nonsteroidal anti-inflammatory drugs (NSAIDs). Further analysis revealed a positive curvilinear association between albumin and MMSE, with cutoff values of 3.9. As concentration serum albumin increased, the risk of severe motor impairment was grown [odds ratio (OR) 0.34 (95% CI 0.14,0.8), P = .013] after adjustment by age, sex, PD duration, MMSE scores, CRP level, and use of NSAIDs. Albumin levels increased per unit of mg/dL, and the risk of PD-related death reduced 0.74-fold with 95% CI (0.15, 0.86) (P = .021), independent of age, sex, PD disease duration, mHY stage, CRP levels, use of NSAIDs, and MMSE. Higher serum albumin levels were significantly association with the better cognitive function when albumin was <3.9 mg/dL, and played a protective role in severe motor impairment and PD-related death. |
format | Online Article Text |
id | pubmed-9478219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94782192022-09-19 Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease Sun, Shujun Wen, Yiyong Li, Yandeng Medicine (Baltimore) Research Article The role of albumin in Parkinson disease (PD) is not well understood, our study will investigate the association between the serum albumin level and risk of dementia, motor impairment, as well as survival outcome in PD. Data were obtained from the publicly available dataset in the DRYAD database (https://datadryad.org/). The original prospective study enrolled patients with PD from a single center in Japan between March 2004 and November 2007. Due to missing values, 242 and 274 participants were included in the study, in which we aimed to, respectively, analyze the relationship between serum albumin and cognitive function as well as motor impairment; additionally, 264 participants were included to assess the association between baseline serum albumin levels and risk of PD-related death with a median follow-up of 5.24 years. Compared to patients of the low tertile of albumin levels, Mini-Mental State Examination (MMSE) of patients of middle tertile increased 2.09 [95% confidence interval (CI) (0.45, 3.73), P = .013], independent of age, sex, PD duration, modified Hoehn-Yahr (mHY) stage, C-reactive protein (CRP) level, and use of nonsteroidal anti-inflammatory drugs (NSAIDs). Further analysis revealed a positive curvilinear association between albumin and MMSE, with cutoff values of 3.9. As concentration serum albumin increased, the risk of severe motor impairment was grown [odds ratio (OR) 0.34 (95% CI 0.14,0.8), P = .013] after adjustment by age, sex, PD duration, MMSE scores, CRP level, and use of NSAIDs. Albumin levels increased per unit of mg/dL, and the risk of PD-related death reduced 0.74-fold with 95% CI (0.15, 0.86) (P = .021), independent of age, sex, PD disease duration, mHY stage, CRP levels, use of NSAIDs, and MMSE. Higher serum albumin levels were significantly association with the better cognitive function when albumin was <3.9 mg/dL, and played a protective role in severe motor impairment and PD-related death. Lippincott Williams & Wilkins 2022-09-16 /pmc/articles/PMC9478219/ /pubmed/36123949 http://dx.doi.org/10.1097/MD.0000000000030324 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Sun, Shujun Wen, Yiyong Li, Yandeng Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease |
title | Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease |
title_full | Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease |
title_fullStr | Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease |
title_full_unstemmed | Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease |
title_short | Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease |
title_sort | serum albumin, cognitive function, motor impairment, and survival prognosis in parkinson disease |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478219/ https://www.ncbi.nlm.nih.gov/pubmed/36123949 http://dx.doi.org/10.1097/MD.0000000000030324 |
work_keys_str_mv | AT sunshujun serumalbumincognitivefunctionmotorimpairmentandsurvivalprognosisinparkinsondisease AT wenyiyong serumalbumincognitivefunctionmotorimpairmentandsurvivalprognosisinparkinsondisease AT liyandeng serumalbumincognitivefunctionmotorimpairmentandsurvivalprognosisinparkinsondisease |